Skip to main content
. 2021 Mar 19;13(3):999. doi: 10.3390/nu13030999
ANOVA Analysis of variance
AE Adverse Event
CEAP Clinical-Etiology-Anatomy-Pathophysiology
IC Informed Consent
IGAE Investigator Global Assessment of Efficacy
IGAS Investigator Global Assessment of Safety
IP Investigational Product
ITT Intention to treat
PGAE Patient Global Assessment of Efficacy
QoL Quality of Life
SAE Serious Adverse Event
SD Standard Deviation
VAS Visual Analogue Scale